Targeting brain-derived neurotrophic factor in the medial thalamus for the treatment of central poststroke pain in a rodent model

Approximately 7% to 10% of patients develop a chronic pain syndrome after stroke. This chronic pain condition is called central poststroke pain (CPSP). Recent studies have observed an abnormal increase in the secretion of brain-derived neurotrophic factor (BDNF) in spinal cord tissue after spinal co...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Hsi-Chien, Kuan, Yung-Hui, Shyu, Bai-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472007/
https://www.ncbi.nlm.nih.gov/pubmed/28394853
http://dx.doi.org/10.1097/j.pain.0000000000000915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472007/
https://www.ncbi.nlm.nih.gov/pubmed/28394853
http://dx.doi.org/10.1097/j.pain.0000000000000915

Ejemplares similares